Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ACT vs CQ With Tafenoquine for P. Vivax Mono-infection — Stella

Home/Malaria/ACT vs CQ With Tafenoquine for P. Vivax Mono-infection

View on ClinicalTrials.gov

Recruiting

Back to Malaria trials

ACT vs CQ With Tafenoquine for P. Vivax Mono-infection

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Thailand

Shoklo Malaria Research Unit (SMRU), Mae Sot, Changwat Tak

Key details

Phase

Post-approval study

Sponsor

Shoklo Malaria Research Unit

Collaborators

Mahidol Oxford Tropical Medicine Research Unit, University of Oxford

Enrollment target

~606 participants

Started

June 2023

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.